‘She was fearless' – Tributes to Kerry woman and disabilities advocate
In the 1950s, Thalidomide was a drug to treat morning sickness that was withdrawn in 1961 after it was linked to birth defects.
During childhood, hospitalisations and surgeries were common for Jacqui. This helped shape her independent outlook in activism from an early age and gave her the impetus to make inclusion and support a priority. She returned to education while working and received her BA from UCD
Jacqui was a valued member of the Disabled Persons Organisations Network and played a key role in contributing to many disability policies and initiatives for almost 40 years.
Her role includes input in the forthcoming National Disability Strategy that is symbolic of Jacqui's passion for establishing strategic change for disabled people.
Minister Foley said there is a deep sense of loss in the Department of Children, Disability and Equality as many staff knew Jacqui personally and worked with her and learned from her over many years.
"I would like to extend my sincere sympathy to the Browne family on the passing of their much-treasured Jacqui,' said Minister Foley.
"It was a personal privilege to know Jacqui as a proud Kerry woman full of warmth, wit and welcome for everyone. She was full of passion, compassion and energy in abundance. Jacqui was an eloquent and powerful advocate for people with disabilities and shone a vibrant and necessary light on disability issues,' she added.
The Minister said during Jacqui's lifetime she achieved a tremendous amount and that some of her work might be unfinished but she remains an impetus and inspiration to 'all of us' to complete it.
"We are without doubt the lesser for Jacqui's passing but greater for having had the privilege of knowing her," Minister Foley said.
ADVERTISEMENT
Learn more
In a statement from Independent Living Movement Ireland, Jacqui is described as a person who never sought the limelight, and her involvement in policy work established advancements in disabled people's rights.
'She was a powerful public speaker and much sought after for her ability to connect policy to practice. Whilst Jacqui took on leadership roles, she was a genuine mentor to many Disabled People and saw part of her role to support other Disabled People to take on key roles,' said a spokesperson.
'She was passionate about the collective empowerment of Disabled People and gave her time generously in online workshops to ensure she shared her knowledge and expertise. Those of us who were fortunate enough to know Jacqui as a person knew someone with a passion for life. She had a wicked sense of humour, a passion for conversation. She was a wonderful host to anyone who visited her in Kerry or Dublin, kind and generous.'
The Disability Federation of Ireland also paid tribute to Jacqui saying its members are 'deeply saddened' at her passing.
'Jacqui Browne was a fearless disability advocate who devoted over 35 years to promoting equality and justice for people with disabilities,' said a spokesperson.
'We extend our heartfelt condolences to Jacqui's family, friends, and everyone who knew and worked with her. Her commitment to disability equality changed lives and will continue to shape the movement for generations.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
04-08-2025
- Irish Examiner
'People in London seem to be finding really creative ways to hurt themselves and each other'
Assisting with the surgery of a man who had suffered 'an unfortunate chainsaw attack' is just the sort of medical drama aspiring doctor Rhys Scully thrives on. 'Luckily, the story had a happy ending,' he tells the Irish Examiner. The 23-year-old has spent the last three weeks in London shadowing some of Britain's leading trauma surgeons. It's been a life-changing experience for the UCD student who says it would not have been possible without the support of his community who fundraised to make the dream a reality. Ever since childhood, Rhys says he has loved nothing more than watching Channel 4 show 24 Hours in A&E. So taken was he with the reality show, he was determined to experience Britain's busiest emergency medicine departments for himself. However, it almost didn't happen for Rhys after a shortfall of personal funds threatened to scupper his chances of accepting the offer of a placement in hospitals under the umbrella of the Guy's and St Thomas' NHS Foundation Trust. But when his mother Lynsey told her friends about Rhys's predicament, they came to the rescue. Lynsey started a GoFundMe campaign, raising a total of €6,555 for Rhys's flights, accommodation, and living costs during his placement. The medical student said he was extremely touched by the generosity of those who donated after he applied for the initiative through King's College Hospital in London. 'Some of these people have never even met me,' Rhys said. 'I am so grateful to them for giving me this opportunity. I really hope that none of them have to avail of my services in the future, but at least if they do it can be my way of giving back.' Survival is priority Rhys, who grew up in Carlow, said he has learned so much from the cases he has assisted with. "I saw a very unfortunate chainsaw attack which required a lot of work. It reaches a point where aesthetics isn't the goal anymore. The priority is survival and, after that, function. Some people come out fine, but other injuries are life-changing. "The team that I'm under specialises in plastic surgery, so they deal with putting people back together again. "I've seen some incredible surgeries including nerve repairs. These are people who, if they were anywhere else, would have to undergo amputations. You get lots of people who get into brawls and break bones as a result. The doctors don't ask questions. 'When people throw punches, they tend to fracture their hand in a specific way so doctors know what to look for. People punching walls out of anger is far more common than you think. You'd assume this is something that only happens in movies, but there are at least two surgeries in the hospital each day dealing specifically with this kind of injury "There have been people who have punched doors, windows, and walls, among other things. You see things that you never thought were possible. "To put it bluntly: People in London seem to be finding really creative ways to hurt themselves and each other. This is unfortunate, obviously, but it's also really important to see from a learning point of view. "Unfortunately, this is how medicine works because you can't know how to treat somebody if you haven't see the injury before." Rhys says that, after his placement, he is going to have a "wealth of knowledge about different injuries and creative ways of treating them when I'm back in Ireland". He also praised the team he is working under for their support and generosity. 'The same consultant who can be harsh and will lay down the law in the theatre, only to buy you lunch afterwards because this is the type of person they are. They have the patients' interests at heart in the theatre, and yours when it's all finished. "One of the best parts for me was being asked to select the music to play in the theatre for one of the procedures. That was such a big deal for me and a real honour.' Rhys Scully praised the team he is working under for their support and generosity, which includes, from left: Maleeha Mughal, Dr Ted Welman, and Dr Markos Antonopoulus. He also enjoys the atmosphere of camaraderie. In the space of 10 minutes, you can go from being head to toe in a gown covered in blood and other stuff to sitting outside with a nice latte talking about plans for the weekend And, he says, the most rewarding part of his experience was seeing the difference treatments can make to lives. 'One of the most positive things I have seen from plastic surgery is what it can do for women with breast cancer. There's something called a Diep flap, which is a type of breast reconstruction surgery that uses the patient's own tissue to rebuild the breast after a mastectomy," he says. "These are the kind of positive things I've seen from plastic surgery for breast cancer. In the past, people would have gone for a mastectomy and that would be it. Some are okay with this but, for others, it can have a huge impact on their self-esteem. For many, it's not just an aesthetic thing — it's a personality thing "This is a very personal thing for people to lose, and they suffer a lot as a result. They can reconstruct the breasts now, so they basically look like they did beforehand. It reduces a lot of psychological distress that can come with a mastectomy. "This is a new option that wasn't there before. Of course, there is also the option of implants — but it's nice to be able to use your own natural tissue as well.' Family support Rhys said his mum Lynsey has been a huge support to him throughout his placement. 'Mum has always been an inspiration to me. She was the reason I went into medicine in the first place. "We often watched 24 Hours in A&E together. She has supported me every step of the way. When I was younger, she gave me books and memoirs about doctors to read. "She wanted to make sure that I was 100% committed and was aware of the life that comes with medicine. The year I was born, she was diagnosed with Crohn's disease. It meant that I was constantly coming with her to doctors appointments as a child. While a lot of people hate hospitals, I fell in love with them "I was always asking the doctors questions and watching what they were doing. I saw how they helped people bounce back. Even though I have no aspirations to be a gastroenterologist, I had that same desire to help people.'
Irish Examiner
01-08-2025
- Irish Examiner
FemTech: will tech aimed solving womens' issues create new ones?
Though women constitute half of the world's population and make the majority of household healthcare spending decisions, FemTech — the use of female technology, products, and services to improve women's health and include them in clinical trials — is a recent phenomenon. Despite old-age prejudices and a previous lack of funding and research, the FemTech industry is projected to grow to $97bn (€84bn) by 2035, thanks to a slate of new apps, products, and tech-focused solutions that tap in to the undeveloped women's health market. This is important for three reasons. The first is that women-centric issues, like menstruation and menopause, have traditionally been left out of the research space. Before 1993, women were rarely included in medical trials, and, according to a 2023 paper, women have accounted for less than 35% of participants in early-stage clinical trials. The second is that a number of health conditions, such as heart disease, Alzheimer's and mental health, affect women and men differently. Dr Tanya Mulcahy, director, Health Innovation Hub Ireland. 'The reason women were never included was because of the likes of the Thalidomide scandal; women of childbearing age were banned from trials,' says Dr Tanya Mulcahy, FemTech Ireland founder and Health Innovation Hub Ireland (HIHI) director. 'That was done to protect mothers and children, but it also resulted in companies not bothering with women's health solutions, because their product would have never been approved.' The third is that women are regularly subjected to medical misogyny, a pervasive stigma associated with women's health. Women of all ages endure pain, disrespect, and subpar medical practices. 'Women have absolutely been gaslit as a result of medical misogyny,' according to GP and female health specialist Dr Máire Finn. 'I've regularly had patients tell me their GP didn't believe in menopause. I don't think it's intentional; it's more so a reflection of poor training and a lack of experience.' The narrative on women's health research has been changed by a number of start-ups, many of which are founded on personal stories, like Justyna Strzeszynska and her company, Joii. Joii Founder, Justyna Strzeszynska Strzeszynska had previously worked in investments, yet her heavy periods routinely left her bedridden for a week. Upon being diagnosed with fibroids, something clicked: There is zero standardisation with how periods are tracked. Joii attempts to counteract this with menstrual pads designed for period tracking, as well as an AI-powered app that measures and assesses menstrual flow: 'The current distinction for heavy periods is anything over 80ml, but that was dictated in 1966, so much has changed since then. People are getting periods earlier than ever, and if they don't have the information they need for the 15-minute appointment with their GP, they might never know what exactly is causing them these symptoms.' Joii's product measures clot size, volume, colour, and symptoms to help women on their journey to seek correct and applicable medical advice: 'I was always asked how regularly I would change my pad. But that is so personal — some people change every hour, others don't. This will now allow people to feel empowered going into a doctor's office as they will be able to track exactly.' CLOSING THE GAP The FemTech wave is down to several factors. According to HIHI's new report, exclusively seen by the Irish Examiner, an increased advocacy for funding and innovation in women's health has been seen by way of advancements in digital health, AI, as well as recent economic reports emphasising FemTech as a rapidly growing industry. According to the World Economic Forum, closing the women's health gap could generate $1tn (€870bn) in annual global GDP by 2040. 'And yet, we're still only scratching the surface in finding out what happens in women compared to men,' Dr Mulcahy says. 'For example, hormone cycles impact lots of things; they can impact your cardiac health for the better. It would make anyone think: Could we figure out other things in the future?' Among the high-potential areas for FemTech start-ups is menstrual health, something researchers at ETH Zürich considered when developing MenstruAI, a first-of-its-kind device that detects disease biomarkers through menstrual blood. Like Joii, MenstruAI's technology is also built into a sanitary pad, but differs in that its sensors change colour if certain biomarkers are present. 'To date, menstrual blood has been regarded as waste,' said PhD student Lucas Dosnon, the 2024 study's lead author. 'And we are trying to show, much the same way that heart rate and temperature works with wearable sensors, that it is a valuable source of information.' PhD student Lucas Dosnon Dosnon, under Professor Inge K Herrmann, found menstrual blood to be a niche scentific gap unexplored by the medical industry, and a way to test blood non-invasively. 'It's comparable to venous blood,' he says. 'But it can also give us information about mucus, cell debris, and lots of other things, too.' MenstruAI, which Dosnon hopes will be available to the public in 'two to five years', works similarly to a covid test, in that a visual marker is produced upon certain protein detection. In time, the team hopes it will provide accessible solutions to detect everything from inflammation to tumour development, with diseases that are hard to screen early, such as ovarian cancer, front and centre of their minds. With such high stakes at play, the consideration of false positives and negatives is central to their research. 'So far, we've reached key benchmarks, in terms of validating the fact that we can detect these proteins, measure their quantity, and properly test our technology with a centralised lab,' Dosnon says. 'But, of course, to fully validate the device, we need to undergo larger field studies and reach certain benchmarks for regulatory approval. 'We're also constantly discussing with designers and doctors how to communicate results in a way that doesn't generate more fear or stress. It's critical to get right.' Dr Marie Finn GP. CAUTION Perhaps the greatest promise of FemTech right now is simply more dialogue around women's health, says Dr Finn. However, like with any new change, personal caution should be exercised when using new products: 'Any improvement or work in this area has to be applauded. But something these companies have to be aware of is the sharing of sensitive medical data. 'That said, intimate details have been shared by people for the likes of 23andMe for years now, and people don't seem to care, but I would suggest proceeding with caution on what information you give, to whom you give it, what information you receive, and how to interpret it. 'The best way to use it, in my opinion, is to do so in tandem with a trusted medical person. Don't forget, we gain insights from some of this as well.' The HIHI survey identified that the biggest challenges FemTech companies face relate to investment and regulatory requirements, a lack of specialised expertise, market access, and direct specialised access to clinicians and patients. As a result, they are calling on the Irish Government to include women's health research and FemTech innovation in the National Life Science Strategy, and for innovators, investors, and enablers to invest in the 51%. 'Investing in women's health research and innovation isn't just about equity — it's a catalyst for better healthcare for all,' Dr Mulcahy says. 'Conditions that affect women differently or disproportionately often hold the key to breakthroughs that benefit everyone. The start-ups and new technologies emerging in FemTech are addressing long-overlooked needs, unlocking insights that improve diagnostics, treatments, and system-wide efficiency. 'When we back these innovations, we're not just supporting women — we are supporting indigenous enterprise and we're building a healthier society.'
Irish Independent
31-07-2025
- Irish Independent
Real Health: The addiction episode with Professor Colin O'Gara
Professor Colin O'Gara, Head of Addiction at St. John of God's Hospital and Clinical Professor of Psychiatry at UCD, joins me on the Real Health podcast. Early in the conversation, I asked the professor of Psychiatry to define addiction. He explained, 'The World Health Organization defines it as a persistence with a behaviour be it a process or ingestion of a substance in the face of adverse consequences.' I wanted to find out from the addiction specialist, when do people end up coming in to seek treatment. Professor O'Gara says, 'The person could feel that there's something up. In a lot of cases, addiction is characterized by a lack of insight or otherwise known as denial. It is usually the people around the individual that'll be raising the alarm. People come to me in a variety of ways. Often, it's because they've been encouraged to go and they'll go because somebody wants them to go.' You can listen to the full episode here or wherever you get your podcasts.
